期刊
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY
卷 34, 期 3, 页码 482-484出版社
OXFORD UNIV PRESS
DOI: 10.1093/icvts/ivab262
关键词
Subxiphoid; Thymectomy; Myasthenia gravis
This study investigated the efficacy of subxiphoid thoracoscopic thymectomy in patients with myasthenia gravis. The results showed that the surgery is technically feasible, but more high-quality evidence is needed to support its use.
The treatment options for myasthenia gravis (MG) include medication and thymectomy; thymectomy plus medication provides better remission of MG and reduced risk of recurrence compared with medication alone [1]. We investigated the efficacy of subxiphoid thoracoscopic thymectomy in patients with myasthenia gravis. The data of 37 consecutive cases were reviewed. 2 cases of postoperative myasthenia gravis crisis and 4 cases of residual mediastinal fat tissue were recorded. Moreover, 29 patients presented the neurological outcomes, and complete stable remission was achieved in 5 (17.2%) cases. Subxiphoid thymectomy is technically feasible. High-quality evidence is warranted before this approach can be recommended.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据